Diabetes

The warnings will address 2 issues: the risk of too much acid in the blood and severe urinary tract infections.

The estimate is based on the larger number of Americans now eligible to be treated for high LDL cholesterol, based on guidelines adopted in 2013.

Results come the same week that CDC announced a drop in new cases of diabetes that was confined to white, well-educated Americans.

Results first presented at the American Diabetes Association in June are published. The new drug application has since been filed at FDA.

This year's measures include 60 that will be part of the new Merit-Based Incentive Payment System or MIPS, which was created under legislation that eliminated the Sustainable Growth Rate.

Critics of the Global Energy Balance Network had compared its work to the tactics of big tobacco, which decades ago had sponsored studies to dissuade Americans that cigarettes were dangerous.

Despite the good news, experts warn against being complacent, because new cases are still high among minorities and those with little education.

Relaxed direct-to-consumer advertising restrictions for drugs by the FDA in 1997 has precipitated an increase in prescription drug utilization, not just among Medicare enrollees, but also among non-elderly users.

The link between low testosterone and decreased insulin sensitivity had been shown in previous research.

Diabetes is a growing epidemic in the United States and new research has indicated that half of healthy 45-year-olds will develop pre-diabetes and one-third will develop diabetes at some point.

The American College of Physicians has published a paper in the Annals of Internal Medicine that advices clinicians to prescribe generic drugs whenever possible.

The policy change is aimed at curbing the state's obesity rate as well as comorbidities such as diabetes

What we're reading, November 25, 2015: UnitedHealthcare's decision on healthcare exchange participation, Democratic Presidential candidate's health plan, and conflict of interest between soda company and anti-obesity research group.

A newly approved therapy offers the first new option in years to prevent hyperkalemia.

What we're reading, November 24, 2015: expensive hepatitis C drugs are more cost effective when used earlier; clinicians aren't prescribing generics enough; and half of health 45-year-olds will develop prediabetes.

Terms of the deal with the second-largest pharmacy benefit manager were not disclosed. Pricing for the PCSK9 inhibitor class has been a source of controversy since the cholesterol-fighting drugs were approved this summer.

Community-based organizations are ideally suited for healthcare prevention efforts and provide a needed linkage to medical care provider systems.

The study credited better drugs and improvements in foot inspections and self-care with the reduction.

John Bel Edwards was elected Governor of Louisiana Saturday after promising to expand Medicaid. Hospitals have been eager to see expansion; in the spring, they supported a fee to pay the state's share once the federal government stops paying 100% of expansion costs.

An Interview with Joslin's George King, MD

The findings suggest that addressing heart patients' social needs is the first step toward getting them to exercise more.

Sequence discovery techniques identified sequences of events that led to gaps in diabetic therapies and were used to identify outreach opportunities aimed at improving medication adherence.

The study population took part in the landmark ORIGIN trial, which evaluated hypoglycemia effects in persons with high CV risk and diabetes.

The action by NICE highlights discussion on both sides of the Atlantic about the cost of PCSK9 inhibitors, which lower LDL cholesterol.

This commentary was adapted from an appearance by the authors at Patient-Centered Diabetes Care, a conference jointly presented by The American Journal of Managed Care and Joslin Diabetes Center.